Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.

Mishra P, Florian J, Peter J, Vainorius M, Fried MW, Nelson DR, Birnkrant D.

Gastroenterology. 2017 Sep;153(3):626-631. doi: 10.1053/j.gastro.2017.07.025. Epub 2017 Jul 27. No abstract available.

PMID:
28757271
2.

Noninvasive Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy Since 1979-Reply.

Andrews JG, Soim A, Pandya S, Westfield CP, Ciafaloni E, Fox DJ, Birnkrant DJ, Cunniff CM, Sheehan DW.

Respir Care. 2017 Aug;62(8):1121-1122. doi: 10.4187/respcare.05675. No abstract available.

PMID:
28733321
3.

Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary.

Finder J, Mayer OH, Sheehan D, Sawnani H, Abresch RT, Benditt J, Birnkrant DJ, Duong T, Henricson E, Kinnett K, McDonald CM, Connolly AM.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):512-519. doi: 10.1164/rccm.201703-0507WS. Review.

PMID:
28636407
4.

Pediatric Pulmonology year in review 2016: Part 1.

Birnkrant DJ, Black JB, Tapia IE, Nicolai T, Gower WA, Noah TL.

Pediatr Pulmonol. 2017 Sep;52(9):1226-1233. doi: 10.1002/ppul.23720. Epub 2017 Apr 25. Review.

PMID:
28440921
5.

Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011.

Andrews JG, Soim A, Pandya S, Westfield CP, Ciafaloni E, Fox DJ, Birnkrant DJ, Cunniff CM, Sheehan DW; Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Respir Care. 2016 Oct;61(10):1349-59. doi: 10.4187/respcare.04676. Epub 2016 Aug 9.

6.

Pediatric pulmonology year in review 2015: Part 3.

Birnkrant DJ, Yilmaz O, Nicolai T, Black JB, Mhanna MJ, Noah TL.

Pediatr Pulmonol. 2016 Jul;51(7):747-53. doi: 10.1002/ppul.23413. Epub 2016 Apr 22. Review.

PMID:
27105321
7.

Cardiac phenotype determines survival in Duchenne muscular dystrophy.

Birnkrant DJ, Ararat E, Mhanna MJ.

Pediatr Pulmonol. 2016 Jan;51(1):70-6. doi: 10.1002/ppul.23215. Epub 2015 Jun 10.

PMID:
26097149
8.

Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs.

Mishra P, Murray J, Birnkrant D.

Hepatology. 2015 Oct;62(4):1298-303. doi: 10.1002/hep.27880. Epub 2015 Jun 19.

PMID:
25953139
9.

Pediatric Pulmonology year in review 2014: Part 1.

Noah TL, Yilmaz O, Nicolai T, Birnkrant D, Praud JP.

Pediatr Pulmonol. 2015 Jun;50(6):621-9. doi: 10.1002/ppul.23202. Epub 2015 Apr 17.

PMID:
25891206
10.

Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).

Chan-Tack KM, Kim C, Moruf A, Birnkrant DB.

Antivir Ther. 2015;20(5):561-4. doi: 10.3851/IMP2944. Epub 2015 Feb 10. Review.

PMID:
25667992
11.

FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.

Mishra P, Florian J, Qi K, Zeng W, Naeger LK, Donaldson E, Connelly S, O'Rear J, Price D, Murray J, Birnkrant D.

Gastroenterology. 2014 Dec;147(6):1196-200. doi: 10.1053/j.gastro.2014.10.027. Epub 2014 Oct 27. No abstract available.

PMID:
25449024
12.

Approach to the diagnosis of congenital myopathies.

North KN, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, Amburgey K, Quijano-Roy S, Beggs AH, Sewry C, Laing NG, Bönnemann CG; International Standard of Care Committee for Congenital Myopathies.

Neuromuscul Disord. 2014 Feb;24(2):97-116. doi: 10.1016/j.nmd.2013.11.003. Epub 2013 Nov 18.

13.

Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies.

Chen J, Florian J, Carter W, Fleischer RD, Hammerstrom TS, Jadhav PR, Zeng W, Murray J, Birnkrant D.

Gastroenterology. 2013 Jun;144(7):1450-1455.e2. doi: 10.1053/j.gastro.2013.02.039. Epub 2013 Mar 5.

PMID:
23470616
14.

Clinical experience with intravenous zanamivir under an emergency investigational new drug program in the United States.

Chan-Tack KM, Gao A, Himaya AC, Thompson EG, Singer ME, Uyeki TM, Birnkrant DB.

J Infect Dis. 2013 Jan 1;207(1):196-8. doi: 10.1093/infdis/jis637. Epub 2012 Oct 22. No abstract available.

PMID:
23089591
15.

Reply to Ison et Al.

Sorbello A, Christopher Jones S, Birnkrant D, Dal Pan G.

Clin Infect Dis. 2013 Jan;56(1):165. doi: 10.1093/cid/cis801. Epub 2012 Sep 12. No abstract available.

PMID:
22972860
16.

Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008).

Soon GG, Min M, Struble KA, Chan-Tack KM, Hammerstrom T, Qi K, Zhou S, Bhore R, Murray JS, Birnkrant DB.

AIDS Patient Care STDS. 2012 Aug;26(8):444-53. doi: 10.1089/apc.2011.0278. Epub 2012 Jun 26.

PMID:
22734949
17.

Interferon responsiveness does not change in treatment-experienced hepatitis C subjects: implications for drug development and clinical decisions.

Liu J, Florian J, Birnkrant D, Murray J, Jadhav PR.

Clin Infect Dis. 2012 Sep;55(5):639-44. doi: 10.1093/cid/cis510. Epub 2012 May 31.

PMID:
22652581
18.

Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.

Sorbello A, Jones SC, Carter W, Struble K, Boucher R, Truffa M, Birnkrant D, Gada N, Camilli S, Chan I, Dallas S, Scales T, Kosko R, Thompson E, Goodman J, Francis H, Dal Pan G.

Clin Infect Dis. 2012 Jul;55(1):1-7. doi: 10.1093/cid/cis351. Epub 2012 Apr 5.

PMID:
22491501
19.

Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects.

Liu J, Jadhav PR, Amur S, Fleischer R, Hammerstrom T, Lewis L, Naeger L, O'Rear J, Pacanowski M, Robertson S, Seo S, Soon G, Birnkrant D.

Hepatology. 2013 Mar;57(3):897-902. doi: 10.1002/hep.25764. Epub 2012 Dec 28.

PMID:
22487907
20.

Developmental and behavioral disorders grown up: duchenne muscular dystrophy.

Birnkrant JM, Bennett DS, Noritz GH, Birnkrant DJ.

J Dev Behav Pediatr. 2011 Oct;32(8):609-15. doi: 10.1097/DBP.0b013e31822a27a2. No abstract available.

PMID:
21836526

Supplemental Content

Loading ...
Support Center